M.R. Migliorino

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

C. Gridelli, Federica Perrone, Ciro Gallo et al. · JNCI Journal of the National Cancer Institute · 2003 · 795 citations · Full text

Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study

Silvia Novello, Julien Mazières, In‐Jae Oh et al. · Annals of Oncology · 2018 · 336 citations · Full text

Alectinib in Resected <i>ALK</i> -Positive Non–Small-Cell Lung Cancer

Yi‐Long Wu, Rafał Dziadziuszko, Jin Seok Ahn et al. · New England Journal of Medicine · 2024 · 320 citations

Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy

Andrea Mancuso, M.R. Migliorino, Stefano De Santis et al. · Annals of Oncology · 2005 · 86 citations · Full text

Geriatric Oncology, Aging, Functional/cognitive Capacity +8

LBA2 ALINA: Efficacy and safety of adjuvant alectinib versus chemotherapy in patients with early-stage ALK+ non-small cell lung cancer (NSCLC)

Benjamin Solomon, Jin Seok Ahn, Rafał Dziadziuszko et al. · Annals of Oncology · 2023 · 71 citations

Oncology, Pharmacology, Immune Checkpoint Inhibitor +4